3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
5
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
2
Other hematologic neoplasm
1
Lymphoid
1
CNS
1
Conditions
Lymphoma
156
Lymphoma, Non-Hodgkin
141
Leukemia, Lymphocytic, Chronic, B-Cell
136
Precursor Cell Lymphoblastic Leukemia-Lymphoma
132
Lymphoma, Follicular
112
Lymphoma, Large B-Cell, Diffuse
111
Lymphoma, Mantle-Cell
75
Lymphoma, B-Cell
73
Hodgkin Disease
63
Multiple Myeloma
59
Leukemia
55
Burkitt Lymphoma
51
Recurrence
49
Lymphoma, B-Cell, Marginal Zone
48
Leukemia, Myeloid, Acute
47
Neoplasms
45
Myelodysplastic Syndromes
42
Hematologic Neoplasms
34
Waldenstrom Macroglobulinemia
28
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
18
Lymphoma, T-Cell
17
Leukemia, Biphenotypic, Acute
16
Leukemia, B-Cell
16
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
15
Mycosis Fungoides
15
Lymphoproliferative Disorders
15
Lymphoma, T-Cell, Peripheral
15
Myeloproliferative Disorders
14
Lymphoma, T-Cell, Cutaneous
14
Breast Neoplasms
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Metabolic Syndrome
×
Lymphoid
×
Clear all
NCT04706676
2025-06-11
INTERACT
Rigshospitalet, Denmark
Phase NA
Active not recruiting
132 enrolled